Companies with a Value score of at least 3, ordered by Value score
Celyad Oncology, a clinical-stage biopharmaceutical company, focuses on the development of CAR-T cell-based therapies for the treatment of cancer.
Financière de Tubize S.A., through its interest in UCB, operates as a biopharmaceutical company worldwide.
